{"id":"https://openalex.org/W2913563357","doi":null,"title":"Investigational Antiretroviral Drugs: What is Coming Down the Pipeline.","display_name":"Investigational Antiretroviral Drugs: What is Coming Down the Pipeline.","alternate_titles":[],"publication_year":2018,"publication_date":"2018-04-01","ids":{"openalex":"https://openalex.org/W2913563357","mag":"2913563357","pmid":"https://pubmed.ncbi.nlm.nih.gov/29689540","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5935216"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:4866189","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5935216","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W2913563357"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5935216","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062018854","display_name":"Roy M. Gulick","orcid":"https://orcid.org/0000-0002-1431-8912","observed_orcids":["https://orcid.org/0000-0002-1431-8912"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roy M Gulick","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062018854"],"corresponding_institution_ids":["https://openalex.org/I4387153466"],"apc_list":null,"apc_paid":null,"fwci":4.8015,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.96010001,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"25","issue":"4","first_page":"127","last_page":"132"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.5},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.925000011920929},{"id":"https://openalex.org/keywords/drug-pipeline","display_name":"drug development pipeline","score":0.7400000095367432},{"id":"https://openalex.org/keywords/doravirine","display_name":"doravirine","score":0.8600000143051147},{"id":"https://openalex.org/keywords/bictegravir","display_name":"bictegravir","score":0.7540000081062317},{"id":"https://openalex.org/keywords/cabotegravir","display_name":"cabotegravir","score":1.0},{"id":"https://openalex.org/keywords/fostemsavir","display_name":"fostemsavir","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ibalizumab","display_name":"ibalizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/hiv-entry-inhibitors","display_name":"HIV entry inhibitors","score":0.7670000195503235},{"id":"https://openalex.org/keywords/long-acting-hiv-therapy","display_name":"long-acting HIV therapy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/hiv-pre-exposure-prophylaxis","display_name":"HIV pre-exposure prophylaxis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7778980731964111},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5572183132171631},{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.5047746896743774},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.44265061616897583},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43462979793548584},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37190306186676025},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3668975830078125},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3220658302307129},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29073989391326904}],"mesh":[{"descriptor_ui":"D003839","descriptor_name":"Deoxyadenosines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D065129","descriptor_name":"Pre-Exposure Prophylaxis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmh:oai:europepmc.org:4866189","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5935216","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5935216","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5935216/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Top Antivir Med","raw_type":"Text"},{"id":"pmid:29689540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29689540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Topics in antiviral medicine","raw_type":"Journal Article"},{"id":"mag:2913563357","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29689540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4866189","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5935216","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1988831468","https://openalex.org/W1995101760","https://openalex.org/W2064492827","https://openalex.org/W2072041078","https://openalex.org/W2105495668","https://openalex.org/W2107249411","https://openalex.org/W2151768713","https://openalex.org/W2156631886","https://openalex.org/W2157643243","https://openalex.org/W2416139320","https://openalex.org/W2467247336","https://openalex.org/W2523305619","https://openalex.org/W2560256273","https://openalex.org/W2586083164","https://openalex.org/W2588766650","https://openalex.org/W2617514227","https://openalex.org/W2738541296","https://openalex.org/W2752494178","https://openalex.org/W2753489952"],"related_works":["https://openalex.org/W2323575706","https://openalex.org/W1926800398","https://openalex.org/W2400984383","https://openalex.org/W2026492445","https://openalex.org/W7214929147","https://openalex.org/W70521724","https://openalex.org/W2600839454","https://openalex.org/W1080435269","https://openalex.org/W2199706768","https://openalex.org/W2030298845"],"abstract_inverted_index":{"Over":[0],"the":[1,25,37,149,167,181,187,202],"past":[2],"30":[3],"years,":[4],"antiretroviral":[5,34],"drug":[6],"regimens":[7,116],"for":[8,131,139],"treating":[9],"HIV":[10,29,71,132,140,145,157,190],"infection":[11],"have":[12],"become":[13],"more":[14,18],"effective,":[15],"safer,":[16],"and":[17,72,75,109,112,120,135,161,200],"convenient.":[19],"Despite":[20],"31":[21],"currently":[22],"approved":[23,98,163],"drugs,":[24],"pipeline":[26],"of":[27,189],"investigational":[28,121],"drugs":[30,35],"remains":[31],"full.":[32],"Investigational":[33,55,144],"include":[36,62,96,148],"nucleoside":[38],"analogue":[39,57,84],"reverse":[40,58],"transcriptase":[41,59],"translocation":[42],"inhibitor":[43,153],"(NRTTI)":[44],"MK-8591,":[45],"a":[46,82],"long-acting":[47],"compound":[48],"that":[49],"could":[50],"be":[51],"dosed":[52],"once":[53],"weekly.":[54],"nonnucleoside":[56],"inhibitors":[60,94,147],"(NNRTIs)":[61],"doravirine,":[63],"which":[64,100,123,155,165],"is":[65,101,124],"active":[66,102],"in":[67,79,88,107,114,117,193,197,211,215],"vitro":[68,108],"against":[69,103],"NNRTI-resistant":[70],"was":[73,110],"potent":[74,111],"well-tolerated":[76,113],"when":[77],"used":[78],"combination":[80,115],"with":[81,127,136],"dual-nucleoside":[83],"RTI":[85],"(nRTI)":[86],"backbone":[87],"treatment-naive":[89,118],"individuals.New":[90],"integrase":[91],"strand":[92],"transfer":[93],"(InSTIs)":[95],"recently":[97,162],"bictegravir,":[99],"InSTI-resistant":[104],"viral":[105],"strains":[106],"individuals,":[119],"cabotegravir,":[122],"being":[125],"studied":[126],"monthly":[128],"parenteral":[129],"dosing":[130,138],"maintenance":[133],"treatment":[134],"bimonthly":[137],"preexposure":[141],"prophylaxis":[142],"(PrEP).":[143],"entry":[146],"new":[150],"CD4":[151,168],"attachment":[152],"fostemsavir,":[154],"targets":[156],"envelope":[158],"glycoprotein":[159],"120,":[160],"ibalizumab,":[164],"binds":[166],"receptor.":[169],"This":[170],"article":[171],"summarizes":[172],"presentations":[173],"by":[174],"Roy":[175],"M.":[176],"Gulick,":[177],"MD,":[178],"MPH,":[179],"at":[180,201],"IAS-USA":[182],"continuing":[183],"education":[184],"program,":[185],"Improving":[186],"Management":[188],"Disease,":[191],"held":[192,210],"Los":[194],"Angeles,":[195],"California,":[196],"April":[198],"2017,":[199],"2017":[203],"Ryan":[204],"White":[205],"HIV/AIDS":[206],"Program":[207],"Clinical":[208],"Conference,":[209],"San":[212],"Antonio,":[213],"Texas,":[214],"August":[216],"2017.":[217]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2913563357","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-02-21T00:00:00"}
